文献速递前列腺增生与排尿功能障碍小儿泌尿与泌尿修复

成人脊柱闭合不全患者膀胱逼尿肌内注射A型肉毒毒素的疗效

Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism.
PubMed 文献 · J Urol · 2018-05-08

该多中心回顾性研究纳入2002至2016年间14个中心共125例接受膀胱逼尿肌内A型肉毒毒素注射的成人脊柱闭合不全患者,首次注射总体成功率为62.3%,尿失禁缓解率73.5%,所有尿动力学参数在6至8周显著改善;膀胱顺应性差者成功率显著降低(34.4% vs 86.9%),女性性别和年龄较大为成功预测因素。

要点

  • 成人脊柱闭合不全患者逼尿肌内A型肉毒毒素注射首次总体成功率62.3%,尿失禁缓解率73.5%。
  • 膀胱顺应性差者总体成功率显著低于顺应性良好者(34.4% vs 86.9%)。
  • 女性性别和年龄较大是总体成功的预测因素。

核心结论

  • 逼尿肌内A型肉毒毒素注射对伴有逼尿肌过度活动的成人脊柱闭合不全患者有效。
  • 膀胱顺应性差的成人脊柱闭合不全患者疗效显著降低。
  • 女性性别和年龄较大是总体成功的其他预测因素。

研究设计与样本

  • 多中心回顾性研究,纳入2002至2016年14个中心接受逼尿肌内A型肉毒毒素注射的成人脊柱闭合不全患者共125例。
  • 主要终点为注射总体成功,主观定义为急迫感、尿失禁和逼尿肌过度活动/低膀胱顺应性均缓解。
  • 采用单因素和多因素分析寻找总体成功的预测因素。

主要发现

  • 首次注射总体成功率为62.3%,尿失禁缓解率为73.5%。
  • 与基线相比,6至8周时所有尿动力学参数显著改善:最大逼尿肌压力下降12 cm H2O(p <0.001),最大膀胱测压容量增加86.6 ml(p <0.001),顺应性增加8.9 ml/cm H2O(p = 0.002)。
  • 561次逼尿肌内A型肉毒毒素注射共记录20例并发症(3.6%),包括3例肌肉无力并发症。
  • 膀胱顺应性差者首次注射总体成功率显著低于顺应性良好者(34.4% vs 86.9%,OR 0.08,p <0.001)。
  • 多因素分析显示膀胱顺应性差与总体成功率降低相关(OR 0.13,p <0.001);女性性别(OR 3.53,p = 0.01)和患者年龄(OR 39.9,p <0.001)为总体成功的预测因素。

临床怎么用

  • 对于伴有逼尿肌过度活动的成人脊柱闭合不全患者,可考虑逼尿肌内A型肉毒毒素注射治疗。
  • 治疗前应评估膀胱顺应性,顺应性差者预期成功率较低,需权衡获益与风险。
  • 女性及年龄较大的成人患者可能获得更高的总体成功率。

局限性

  • 回顾性研究设计。
  • 总体成功定义为主观组合终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the current study was to determine the outcomes of botulinum toxin A intradetrusor injections in adult patients with spina bifida. MATERIALS AND METHODS: All patients with spinal dysraphism who underwent intradetrusor injections of botulinum toxin A from 2002 to 2016 at a total of 14 centers were retrospectively included in analysis. The primary end point was the global success of injections, defined subjectively as the combination of urgency, urinary incontinence and detrusor overactivity/low bladder compliance resolution. Univariate and multivariate analysis was performed to seek predictors of global success. RESULTS: A total of 125 patients were included in study. The global success rate of the first injection was 62.3% with resolution of urinary incontinence in 73.5% of patients. All urodynamic parameters had improved significantly by 6 to 8 weeks compared to baseline, including maximum detrusor pressure (-12 cm H2O, p <0.001), maximum cystometric capacity (86.6 ml, p <0.001) and compliance (8.9 ml/cm H2O, p = 0.002). A total of 20 complications (3.6%) were recorded for the 561 intradetrusor botulinum toxin A injections, including 3 muscular weakness complications. The global success rate of the first injection was significantly lower in patients with poor compliance (34.4% vs 86.9%, OR 0.08, p <0.001). On multivariate analysis poor compliance was associated with a lower global success rate (OR 0.13, p <0.001). Female gender (OR 3.53, p = 0.01) and patient age (OR 39.9, p <0.001) were predictors of global success. CONCLUSIONS: Intradetrusor botulinum toxin A injections were effective in adult patients with spina bifida who had detrusor overactivity. In contrast, effectiveness was much lower in adult patients with spina bifida who had poor bladder compliance. The other predictors of global success were female gender and older age.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Peyronnet B, Even A, Capon G, et al. Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism. J Urol. 2018. PMID: 29746860. doi:10.1016/j.juro.2018.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。